Peak, one of the telemedicine companies advertising psychedelic therapy via ketamine doses on TikTok, has announced they are “winding down” their controversial membership service.
Less than a month after Rolling Stone reported on how “personalized psychedelic therapy programs” have been promoting ads aimed at zoomers on social media sites like TikTok, Peak’s website was updated recently to reveal that the service would stop accepting new customers immediately before closing for good on Nov. 30.
“Since day one, our main goal has been to provide safe, guided access to life-changing treatments for anxiety and depression.
Less than a month after Rolling Stone reported on how “personalized psychedelic therapy programs” have been promoting ads aimed at zoomers on social media sites like TikTok, Peak’s website was updated recently to reveal that the service would stop accepting new customers immediately before closing for good on Nov. 30.
“Since day one, our main goal has been to provide safe, guided access to life-changing treatments for anxiety and depression.
- 9/18/2022
- by Daniel Kreps
- Rollingstone.com
“My life when I was on SSRIs and doing talk therapy: Struggling to sleep, not eating, and still feeling no relief,” the TikTok’s caption reads. A man with close-cropped facial hair and a warm, approachable face lies in bed. “Sunroof” by Nicky Youre and Dazy plays in the background. As if to emphasize the point, he tosses and turns, grimacing.
As the instrumental kicks in, the scene abruptly shifts to a busy Penn Station intersection, hues brightening like Dorothy entering Oz, the man’s face spread into a grin.
As the instrumental kicks in, the scene abruptly shifts to a busy Penn Station intersection, hues brightening like Dorothy entering Oz, the man’s face spread into a grin.
- 8/27/2022
- by EJ Dickson
- Rollingstone.com
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.